Crinetics Pharmaceuticals Inc
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. It offers a pipeline of oral nonpeptide (small molecule) new chemical entities that target peptide G protein coupled receptors (GPCRs) to treat a variety of rare endocrine diseases. The Company's product candidates include paltusotine and CRN04894. Its paltusotine is in clinical development for the treatment of acromegaly and neuroendocrine tumors complicated by carcinoid syndrome. CRN04894 is in clinical development for diseases of excess adrenocorticotrophic hormone (ACTH), including Cushing's disease and congenital adrenal hyperplasia (CAH). The Company's subsidiary is Crinetics Australia Pty Ltd.
Buy US stocks in Australia starting with CRNX. Open an account and start investing today!
Ready to start your investing journey with Stake?Open an account
To do so follow these steps:
- Sign up in minutes, all you need is some I.D.
- Choose Stake Wall St
- Deposit directly into your Stake wallet and you're ready to invest in CRNX
This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in CRNX
Buy CRNX from US$3 brokerage
Invest in 6,000+ U.S. stocks and ETFs
Own a slice of CRNX from only US$10 with fractional shares